HOme USability Evaluation (HOUSE)

Entia

Status: Not yet enrolling

Conditions: Cancer

Treatments: Device: Entia Liberty

Study type: Observational

Funder types: Industry

Identifiers

NCT06134245

IRAS ID: 336920

Details and patient eligibility

About

To validate the usability and safety of the Liberty Analyser.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Undergoing systemic anti-cancer therapy (SACT)
• Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment
• Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser
• Patients capable of providing written informed consent

Exclusion criteria

• History or current diagnosis of haematological malignancy
• Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training
• Inadequate use and understanding of the English language, requiring a translator